Azilsartan: Current Evidence and Perspectives in Management of Hypertension

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Hypertension is a widespread global health issue with significant mortality and economic impact.
• Effective blood pressure control often necessitates combination drug therapy.
• Angiotensin receptor blockers (ARBs) are a key class of antihypertensive medications.

Purpose of the Study:

• To review the role of azilsartan in contemporary hypertension management.
• To highlight azilsartan's potency and safety profile compared to other ARBs.

Main Methods:

• Literature review of clinical trials and pharmacological studies.
• Comparative analysis of azilsartan's efficacy and tolerability against other ARBs.
• Examination of azilsartan's pharmacokinetic and pharmacodynamic properties.

Main Results:

• Azilsartan demonstrates superior potency in head-to-head trials compared to other ARBs.
• Azilsartan is associated with a favorable side effect profile.
• It offers effective blood pressure reduction in hypertensive patients.

Conclusions:

• Azilsartan represents a potent and well-tolerated option for hypertension management.
• Its efficacy supports its use as a cornerstone therapy, potentially simplifying combination regimens.
• Further research should explore its long-term cardiovascular outcomes.